Robert F. Werner, an officer of Twist Bioscience Corp, filed a Form 144 notice on November 20, 2026, proposing the sale of 8,275 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
Key Highlights
- Proposed sale: Werner intends to sell 8,275 shares of Twist Bioscience Corp common stock, with an aggregate market value of $860,856.53, according to the filing.
- Shares outstanding: The filing states 68,178,692 shares of common stock were outstanding at the time of notice.
- Acquisition source: All shares to be sold were acquired through restricted stock vesting from the issuer, classified as compensation, across eleven vesting events between February 20, 2026 and November 12, 2026.
- Recent sales history: Werner sold a combined 5,028 shares in six separate transactions between August 21, 2026 and November 16, 2026, generating total gross proceeds of $712,142.78.
- Broker: The proposed sale is to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
- Approximate sale date: The filing lists November 20, 2026 as the approximate date of sale.
Werner's Proposed Share Sale: Vested Compensation Behind the Notice
According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 20, 2026, Robert F. Werner, identified as an officer of Twist Bioscience Corp (NASDAQ:TWST), provided notice of a proposed sale of 8,275 shares of the company's common stock. The filing identifies Fidelity Brokerage Services LLC as the executing broker, with an aggregate market value for the proposed sale listed as $860,856.53.
The filing details eleven separate restricted stock vesting events as the source of the shares to be sold. These vesting dates ranged from February 20, 2026 through November 12, 2026, with individual vesting amounts of 496, 188, 1,075, 299, 185, 878, 1,021, 293, 1,898, 204, and 1,738 shares, respectively, all acquired from the issuer and classified as compensation. No shares were identified as gifts.
The filing also discloses that Werner sold 5,028 shares in six transactions during the three months preceding the notice. Those sales occurred on August 21, August 24, September 8, October 2, November 3, and November 16, 2026, with gross proceeds of $93,035.42, $120,219.72, $29,184.49, $279,925.79, $20,039.45, and $169,737.91, respectively. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Robert F. Werner.
What Was Disclosed
Twist Bioscience Corp officer Robert F. Werner filed a Form 144 on November 20, 2026, proposing to sell 8,275 shares of common stock valued at $860,856.53. All shares were acquired through restricted stock vesting as compensation between February and November 2026.


Please wait processing your request...